Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07606313 · ClinicalTrials.gov registry record · NA
Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES Trial
A NA study, sponsored by OHSU Knight Cancer Institute.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07606313: Clinical Trial NA study, sponsored by OHSU Knight Cancer Institute.
NCT07606313 is a NA study that has not yet begun recruiting, run by OHSU Knight Cancer Institute. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07606313, a NA study, has not yet begun recruiting, sponsored by OHSU Knight Cancer Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The study will assess the feasibility and preliminary efficacy of live, online supervised group functional resistance training in older cancer survivors who may have difficulty with independent functioning. The study design is a three-arm parallel group randomized controlled trial (immediate resistance training, delayed resistance training, stretching placebo) in 150 older cancer survivors. The resistance training program will be compared to two different types of common control groups: a stretching placebo group and a delayed intervention group. By using two control conditions, this study can also inform the design of future randomized trials on the selection of an appropriate control group.
Primary Outcome
Measured by the percentage of enrolled participants not completing baseline and 16-week survey or performance testing.
Interventions
- OTHER Stretching
- OTHER Functional Resistance Training
- OTHER Delayed Functional Resistance Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What is known before NCT07606313 opens enrollment
NCT07606313 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Stretching is the first listed.
NCT07606313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07606313 about?
NCT07606313 is a clinical study titled "Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES Trial". The study will assess the feasibility and preliminary efficacy of live, online supervised group functional resistance training in older cancer survivors who may have difficulty with independent functioning. The study design is a three-arm parallel group randomized controlled trial (immediate resista...
What is the current status of trial NCT07606313?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-05-18. Estimated completion is 2028-08-31.
What interventions are being tested in trial NCT07606313?
The interventions under investigation include: Stretching (OTHER), Functional Resistance Training (OTHER), Delayed Functional Resistance Training (OTHER).
Who is sponsoring clinical trial NCT07606313?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07606313's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI